These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20029235

  • 1. Noonan syndrome: growth to growth hormone - the experience of observational studies.
    Ranke MB.
    Horm Res; 2009 Dec; 72 Suppl 2():36-40. PubMed ID: 20029235
    [Abstract] [Full Text] [Related]

  • 2. GH therapy in Noonan syndrome: Review of final height data.
    Dahlgren J.
    Horm Res; 2009 Dec; 72 Suppl 2():46-8. PubMed ID: 20029237
    [Abstract] [Full Text] [Related]

  • 3. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
    Binder G.
    Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R, Camacho-Hübner C, Attie KM, Savage MO.
    Horm Res; 2008 Dec; 70(3):129-36. PubMed ID: 18663312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA, Dana K, Bakker B, Davis DA, Hunold JJ, Jacobs J, Lippe B.
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [Abstract] [Full Text] [Related]

  • 8. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
    Zavras N, Meazza C, Pilotta A, Gertosio C, Pagani S, Tinelli C, Bozzola M.
    Ital J Pediatr; 2015 Oct 06; 41():71. PubMed ID: 26444854
    [Abstract] [Full Text] [Related]

  • 9. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO, Padidela R, Kirk JM, Malaquias AC, Jorge AA.
    Pediatr Endocrinol Rev; 2009 Jun 06; 6 Suppl 4():523-8. PubMed ID: 19550387
    [Abstract] [Full Text] [Related]

  • 10. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Jun 06; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone and the heart in Noonan syndrome.
    Noordam C.
    Horm Res; 2009 Dec 06; 72 Suppl 2():49-51. PubMed ID: 20029238
    [Abstract] [Full Text] [Related]

  • 12. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G, Neuer K, Ranke MB, Wittekindt NE.
    J Clin Endocrinol Metab; 2005 Sep 06; 90(9):5377-81. PubMed ID: 15985475
    [Abstract] [Full Text] [Related]

  • 13. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Sep 06; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr 06; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

  • 15. Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.
    Choi JH, Lee BH, Jung CW, Kim YM, Jin HY, Kim JM, Kim GH, Hwang JS, Yang SW, Lee J, Yoo HW.
    Horm Res Paediatr; 2012 Apr 06; 77(6):388-93. PubMed ID: 22777296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth hormone treatment for short stature in children born small for gestational age.
    Jung H, Rosilio M, Blum WF, Drop SL.
    Adv Ther; 2008 Oct 06; 25(10):951-78. PubMed ID: 18836868
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.
    Noonan JA, Kappelgaard AM.
    Horm Res Paediatr; 2015 Oct 06; 83(3):157-66. PubMed ID: 25503994
    [Abstract] [Full Text] [Related]

  • 19. [The Noonan syndrome from a pediatric perspective].
    Noordam C, Thoonen G, van der Burgt CJ.
    Ned Tijdschr Geneeskd; 2003 Apr 05; 147(14):644-8. PubMed ID: 12712646
    [Abstract] [Full Text] [Related]

  • 20. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
    Ferreira LV, Souza SA, Arnhold IJ, Mendonca BB, Jorge AA.
    J Clin Endocrinol Metab; 2005 Sep 05; 90(9):5156-60. PubMed ID: 15956085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.